Cargando…

Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets

Detalles Bibliográficos
Autor principal: Souza, Rhonda F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924751/
https://www.ncbi.nlm.nih.gov/pubmed/29713671
http://dx.doi.org/10.1016/j.jcmgh.2018.01.020
_version_ 1783318586924728320
author Souza, Rhonda F.
author_facet Souza, Rhonda F.
author_sort Souza, Rhonda F.
collection PubMed
description
format Online
Article
Text
id pubmed-5924751
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59247512018-04-30 Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets Souza, Rhonda F. Cell Mol Gastroenterol Hepatol Editorial Elsevier 2018-02-15 /pmc/articles/PMC5924751/ /pubmed/29713671 http://dx.doi.org/10.1016/j.jcmgh.2018.01.020 Text en © 2018 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Souza, Rhonda F.
Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets
title Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets
title_full Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets
title_fullStr Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets
title_full_unstemmed Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets
title_short Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets
title_sort esophageal adenocarcinomas: a need for speed driven by immune pathways that have druggable targets
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924751/
https://www.ncbi.nlm.nih.gov/pubmed/29713671
http://dx.doi.org/10.1016/j.jcmgh.2018.01.020
work_keys_str_mv AT souzarhondaf esophagealadenocarcinomasaneedforspeeddrivenbyimmunepathwaysthathavedruggabletargets